4//SEC Filing
Jacobs John C 4
Accession 0001593968-25-000137
CIK 0001000694other
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:19 PM ET
Size
8.3 KB
Accession
0001593968-25-000137
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Jacobs John C
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2025-01-23$9.55/sh−38,873$371,237→ 91,849 total - Exercise/Conversion
Common Stock
2025-01-23+83,196→ 130,722 total - Exercise/Conversion
Restricted Stock Units
2025-01-23−83,196→ 83,197 totalExercise: $0.00Exp: 2033-01-23→ Common Stock (83,196 underlying)
Footnotes (1)
- [F1]One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001820836
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:19 PM ET
- Size
- 8.3 KB